Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1966 5
1967 2
1968 2
1969 4
1970 2
1971 1
1972 1
1973 2
1974 4
1976 10
1977 4
1978 5
1979 5
1980 7
1981 8
1982 6
1983 6
1984 13
1985 7
1986 17
1987 13
1988 25
1989 25
1990 24
1991 35
1992 45
1993 48
1994 64
1995 50
1996 63
1997 86
1998 100
1999 136
2000 193
2001 201
2002 233
2003 299
2004 315
2005 387
2006 428
2007 456
2008 532
2009 634
2010 760
2011 869
2012 955
2013 1088
2014 1065
2015 1125
2016 1170
2017 1212
2018 1223
2019 1260
2020 1375
2021 1481
2022 1337
2023 1215
2024 1248
2025 1287
2026 809

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21,323 results

Results by year

Filters applied: . Clear all
Page 1
Assessment of tumor mutation burden based on whole-exome sequencing of extracellular vesicle-derived DNA from bronchoalveolar lavage fluid in advanced non-small cell lung cancer treated with pembrolizumab: a prospective, multicenter, observational study.
Kim H, Hur J, Kim WS, Kim IA, Park D, Oh IJ, Noh SJ, Bang H, Lee KY. Kim H, et al. Among authors: kim ws. Transl Lung Cancer Res. 2026 Jun 30;15(6):176. doi: 10.21037/tlcr-2026-0294. Epub 2026 Jun 24. Transl Lung Cancer Res. 2026. PMID: 42433255 Free PMC article.
Delphi survey to explore core curriculum for training the next-generation of hepatologists☆.
Xu X, Shi Y, Tacke F, Wai-Sun Wong V, Li W, Sebastiani G, Newsome PN, Romero-Gomez M, Pan C, Castera L, Chai J, Kim W, Valenti L, Yilmaz Y, Win KM, Xu X, Ocama P, Ghazinyan H, Al Mahtab M, Hamid S, Lesmana CRA, Romeo S, Castellanos Fernandez MI, Yu X, Luukkonen PK, Takahashi H, Charatcharoenwitthaya P, Boursier J, Cua IH, Dao HV, Spearman CW, Bandara Dassanayake SU, Ayurzana M, Aghayeva G, Muthiah MD, Mendez-Sanchez N, Stedman CA, Alswat K, Sharara AI, Debzi N, Leite NC, Alkhatry MS, van Kleef LA, Barakat S, Al-Busafi SA, Agyei-Nkansah A, Fouad Y, Gracia-Sancho J, Lupsor-Platon M, Ryan JD, Chan WK, Cortez-Pinto H, Mandorfer M, Duseja A, Papatheodoridis G, Francque SM, Byrne CD, Targher G, George J, Zheng MH; Global Hepatology Training Consortium. Xu X, et al. Among authors: kim w. JHEP Rep. 2026 Jul 8:101942. doi: 10.1016/j.jhepr.2026.101942. Online ahead of print. JHEP Rep. 2026. PMID: 42419486 Free article.
Efficacy, safety, and dose selection of efepoetin alfa in anemic patients on maintenance dialysis: a phase 2, randomized, multicenter, active-controlled trial.
Ko EJ, Byun MS, Yang CW, Shin SK, Kim HW, Shin BC, Shin SJ, Park HC, Kang YS, Lee SH, Song HC, Kim SH, Na KY, Jo YI, Kim W, Seong EY, Kim YL, Ryu H, Kim H, Choi YJ, Chung BH. Ko EJ, et al. Among authors: kim w. Kidney Res Clin Pract. 2026 Jul 8. doi: 10.23876/j.krcp.26.080. Online ahead of print. Kidney Res Clin Pract. 2026. PMID: 42415611 Free article.
21,323 results
You have reached the last available page of results. Please see the User Guide for more information.